These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35253349)

  • 1. Laser vaporization of atherothrombotic burden before drug-coated balloon application in ST-segment elevation myocardial infarction: Two-year outcomes of the laser-DCB trial.
    Tonomura D; Shimada Y; Yamanaka Y; Terashita K; Suzuki T; Nishiura S; Yoshida M; Tsuchida T; Fukumoto H
    Catheter Cardiovasc Interv; 2022 May; 99(6):1758-1765. PubMed ID: 35253349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REVascularization with paclitaxEL-coated balloon angioplasty versus drug-eluting stenting in acute myocardial infarcTION-A randomized controlled trial: Rationale and design of the REVELATION trial.
    Vos NS; van der Schaaf RJ; Amoroso G; Herrman JP; Patterson MS; Slagboom T; Vink MA
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1213-21. PubMed ID: 26370515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction: The REVELATION Randomized Trial.
    Vos NS; Fagel ND; Amoroso G; Herrman JR; Patterson MS; Piers LH; van der Schaaf RJ; Slagboom T; Vink MA
    JACC Cardiovasc Interv; 2019 Sep; 12(17):1691-1699. PubMed ID: 31126887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
    [No Abstract]   [Full Text] [Related]  

  • 5. Real-life experience of a stent-less revascularization strategy using a combination of excimer laser and drug-coated balloon for patients with acute coronary syndrome.
    Harima A; Sairaku A; Inoue I; Nishioka K; Oka T; Nakama Y; Dai K; Ohi K; Hashimoto H; Kihara Y
    J Interv Cardiol; 2018 Jun; 31(3):284-292. PubMed ID: 29464846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: the nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial.
    Nijhoff F; Agostoni P; Belkacemi A; Nathoe HM; Voskuil M; Samim M; Doevendans PA; Stella PR
    Catheter Cardiovasc Interv; 2015 Oct; 86 Suppl 1():S34-44. PubMed ID: 26119971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Ultrasound-Controlled Paclitaxel Releasing Balloon vs. Asymmetric Drug-Eluting Stent in Primary ST-Segment Elevation Myocardial Infarction　- A Prospective Randomized Trial.
    Wang Z; Yin Y; Li J; Qi W; Yu B; Xu Z; Zhu W; Yang F; Cao M; Zhang H
    Circ J; 2022 Mar; 86(4):642-650. PubMed ID: 34759131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the excimer laser on myocardial salvage in ST-elevation acute myocardial infarction via nuclear scintigraphy.
    Shibata N; Takagi K; Morishima I; Yoshioka N; Furui K; Nagai H; Kanzaki Y; Yoshida R; Morita Y; Tsuboi H; Murohara T
    Int J Cardiovasc Imaging; 2020 Jan; 36(1):161-170. PubMed ID: 31451993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-Year Clinical Outcomes of the REVELATION Study: Sustained Safety and Feasibility of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction.
    Niehe SR; Vos NS; Van Der Schaaf RJ; Amoroso G; Herrman JR; Patterson MS; Slagboom T; Vink MA
    J Invasive Cardiol; 2022 Jan; 34(1):E39-E42. PubMed ID: 34792482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Paclitaxel Drug-Coated Balloon Only Angioplasty in STEMI.
    Merinopoulos I; Gunawardena T; Corballis N; Bhalraam U; Reinhold J; Wickramarachchi U; Maart C; Gilbert T; Richardson P; Sulfi S; Sarev T; Sawh C; Wistow T; Ryding A; Mohamed MO; Perperoglou A; Mamas MA; Vassiliou VS; Eccleshall SC
    JACC Cardiovasc Interv; 2023 Apr; 16(7):771-779. PubMed ID: 37045498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the debulking by excimer laser coronary angioplasty on long-term outcome compared with drug-coating balloon: insights from optical frequency domain imaging analysis.
    Sato T; Tsuchida K; Yuasa S; Taya Y; Koshikawa T; Tanaka K; Fujita S; Ikeda Y; Takahashi M; Okabe M; Oda H; Aizawa Y
    Lasers Med Sci; 2020 Mar; 35(2):403-412. PubMed ID: 31264007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of In-Stent Restenosis by Excimer Laser Coronary Atherectomy and Drug-Coated Balloon: Serial Assessment with Optical Coherence Tomography.
    Miyazaki T; Ashikaga T; Fukushima T; Hatano Y; Sasaoka T; Kurihara K; Ono Y; Shimizu S; Otomo K; Hirao K
    J Interv Cardiol; 2019; 2019():6515129. PubMed ID: 31772538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser Vaporization of Intracoronary Thrombus and Identifying Plaque Morphology in ST-Segment Elevation Myocardial Infarction as Assessed by Optical Coherence Tomography.
    Yamanaka Y; Shimada Y; Tonomura D; Terashita K; Suzuki T; Yano K; Nishiura S; Yoshida M; Tsuchida T; Fukumoto H
    J Interv Cardiol; 2021; 2021():5590109. PubMed ID: 34393666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results From the International Drug Coated Balloon Registry for the Treatment of Bifurcations. Can a Bifurcation Be Treated Without Stents?
    Bruch L; Zadura M; Waliszewski M; Platonic Z; Eränen J; Scheller B; Götting B; Herberger D; Palmieri C; Sinicròpi G; Motz W
    J Interv Cardiol; 2016 Aug; 29(4):348-56. PubMed ID: 27242273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiographic and clinical performance of polymer-free biolimus-eluting stent in patients with ST-segment elevation acute myocardial infarction in a metropolitan public hospital: The BESAMI MUCHO study.
    Sgueglia GA; D'Errico F; Gioffrè G; De Santis A; Summaria F; Piccioni F; Gaspardone A
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):851-858. PubMed ID: 28766881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the safety and effectiveness of drug-coated balloons in patients with acute myocardial infarction.
    Hao X; Huang D; Wang Z; Zhang J; Liu H; Lu Y
    J Cardiothorac Surg; 2021 Jun; 16(1):178. PubMed ID: 34154628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Coated Balloon Versus Drug-Eluting Stent in Primary Percutaneous Coronary Intervention: A Feasibility Study.
    Gobić D; Tomulić V; Lulić D; Židan D; Brusich S; Jakljević T; Zaputović L
    Am J Med Sci; 2017 Dec; 354(6):553-560. PubMed ID: 29208251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes.
    Belkacemi A; Agostoni P; Nathoe HM; Voskuil M; Shao C; Van Belle E; Wildbergh T; Politi L; Doevendans PA; Sangiorgi GM; Stella PR
    J Am Coll Cardiol; 2012 Jun; 59(25):2327-37. PubMed ID: 22503057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.